Best Alkylating Drug for lymphoma, non-hodgkin
3 Alkylating Drug drugs indicated for lymphoma, non-hodgkin, ranked by our independent rating. The current highest-rated is vivimusta. Compare them with all treatments for lymphoma, non-hodgkin or the full Alkylating Drug class. Not medical advice — always consult a professional.
Top alkylating drug for lymphoma, non-hodgkin: 1. Vivimusta · 2. Bendeka · 3. Treanda
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Vivimusta | 72/100 | Prescription | — | View → |
| 2 | Bendeka | Not yet rated | Prescription | — | View → |
| 3 | Treanda | Not yet rated | Prescription |
Full ranking · 3 drugs
Frequently asked
- What is the best alkylating drug for lymphoma, non-hodgkin?
- By our independent rating, vivimusta currently ranks highest among Alkylating Drug drugs used for lymphoma, non-hodgkin. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which alkylating drug drugs treat lymphoma, non-hodgkin?
- pharmaranks lists 3 Alkylating Drug products indicated for lymphoma, non-hodgkin, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.